Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Gastroenterology. 2021 Sep 3;161(6):1887–1895.e4. doi: 10.1053/j.gastro.2021.08.050

Table 4.

Illustrative low-, intermediate- and high-risk cases with MELD, MELDNa and MELD 3.0 scores

Risk Level
Low Intermediate High
Data
Sex M F M M F M M F
Bilirubin 2.5 2.5 6.0 6.0 6.0 12.0 12.0 12.0
Na 131 131 131 131 131 128 128 128
INR 1.0 1.0 1.5 1.5 1.5 2.2 2.2 2.2
Creatinine 1.2 1.2 1.5 1.5 1.5 1.8 2.8 2.8
Albumin 3.8 3.8 3.5 2.2 2.2 2.0 2.0 2.0
Scores
MELD 12 12 22 22 22 30 35 35
MELDNa 18 18 26 26 26 33 36 36
MELD 3.0 16 17 25 26 27 34 38 39
Delta* −2 −1 −1 0 1 1 2 3
MELD 3.0 no albumin 16 18 25 25 27 34 39 40
Predicted Mortality
30 day 0.9% 1.1% 4.3% 5.3% 6.4% 19.8% 35.8% 41.8%
90 day 2.6% 3.1% 12.1% 14.5% 17.5% 47.1% 72.3% 79.1%
*

Difference between MELDNa and MELD 3.0 (Delta score = MELD 3.0 - MELDNa)